Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1

BACKGROUND: To develop cancer antigen-targeted immunotherapeutic strategies for malignant pleural mesothelioma (MPM), we investigated the individual and coexpressions of the cancer-associated antigens mesothelin (MSLN), cancer antigen 125 (CA125), and Wilms tumor 1 (WT1) in both epithelioid and non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Eguchi, Takashi, Kadota, Kyuichi, Mayor, Marissa, Zauderer, Marjorie G., Rimner, Andreas, Rusch, Valerie W., Travis, William D., Sadelain, Michel, Adusumilli, Prasad S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652821/
https://www.ncbi.nlm.nih.gov/pubmed/29100432
http://dx.doi.org/10.18632/oncotarget.20845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652821/
https://www.ncbi.nlm.nih.gov/pubmed/29100432
http://dx.doi.org/10.18632/oncotarget.20845

Ejemplares similares